A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

NCT01208181 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1404

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Etoricoxib 60 mg
DRUG: Etoricoxib 90 mg
DRUG: Placebo to Etoricoxib 60 mg
DRUG: Placebo to Etoricoxib 90 mg

Sponsor

Organon and Co